National Comprehensive Cancer Network



About NCCN

Genetic/Familial High-Risk Assessment: Breast and Ovarian Panel - Disclosures as of 10/20/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Jennifer E. Axilbund, MS, CGC

None

None

None

None

10/8/2014

Marian Birkeland

None

None

None

None

10/7/2014

Saundra S. Buys, MD

None

None

None

None

4/28/2014

Beth Crawford, MS, CGC

None

None

None

None

11/22/2013

Mary B. Daly, MD, PhD, FACP

None

None

None

None

9/26/2014

Mary Dwyer, MS

None

None

None

None

10/9/2014

Meagan Farmer, CGC

None

None

None

None

7/8/2014

Susan Friedman, DVM

None

None

None

None

10/3/2014

Judy E. Garber, MD, MPH

AstraZeneca Pharmaceuticals LP;
Myriad Genetic Laboratories, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

Biomarin;
Tesaro

None

None

11/14/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

Carolyn Horton, MS

None

None

None

None

11/15/2013

Seema Khan, MD

None

None

None

None

11/1/2013

Catherine Klein, MD

None

None

None

None

10/14/2014

Wendy Kohlmann, MS, CGC

None

Myriad Genetic Laboratories, Inc.

None

None

10/3/2014

Rashmi Kumar, PhD

None

None

None

None

5/6/2014

Allison Kurian, MD, MSc

Genomic Health, Inc.;
Myriad Genetic Laboratories, Inc.;
BiPar Sciences/Sanofi-Aventis;
InVitae Corporation

None

None

None

8/14/2014

Jennifer Litton, MD

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Baylor College of Medicine;
Biomarin;
MD Anderson Cancer Center

None

None

Novartis Pharmaceuticals Corporation;
Biomarin

5/1/2014

Lisa Madlensky, PhD, CGC

None

None

None

None

8/6/2014

P. Kelly Marcom, MD

Abbott Laboratories;
Veridex, LLC

None

None

None

7/20/2014

Joan S. McClure, MS

None

None

None

None

6/20/2014

Sofia D. Merajver, MD, PhD

None

None

None

None

10/9/2014

Kenneth Offit, MD

None

None

None

None

10/2/2014

Tuya Pal, MD, FAAP, FABMG

None

None

None

None

10/3/2014

Robert Pilarski, MS, CGC

None

None

None

None

8/7/2014

Huma Rana, MD

None

None

None

None

8/12/2014

Gwen Reiser, MS, CGC

None

None

None

None

9/22/2014

Mark E. Robson, MD

AstraZeneca Pharmaceuticals LP;
Myriad Genetic Laboratories, Inc.;
AbbVie;
Biomarin

Bayer HealthCare;
Biomarin;
Pfizer Inc.

None

None

8/13/2014

Kristen Mahoney Shannon, MS, CGC

InVitae

None

None

None

9/25/2014

Elizabeth Swisher, MD

None

None

None

None

11/12/2013

Nicoleta C. Voian, MD, MPH

None

None

None

None

9/18/2014

Jeffrey N. Weitzel, MD

None

None

None

None

9/3/2014

Alison Whelan, MD

None

None

None

None

11/7/2012

Myra J. Wick, MD, PhD

None

InformedDNA

None

None

10/11/2014

Georgia L. Wiesner, MD

None

None

None

None

8/14/2014